BDBM50061859 2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-1H-indazole-3-carbonyl)-amino]-propionylamino}-propionic acid::CHEMBL433684

SMILES CCCCS(=O)(=O)NC(CNC(=O)CCNC(=O)c1[nH]nc2cc(ccc12)C(N)=N)C(O)=O

InChI Key InChIKey=ULMWVACPLANFSN-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50061859   

TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061859(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 2nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061859(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 53nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061859(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of vitronectin binding to the purified immobilized vitronectin receptor (alpha v, beta 3).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed